About this trial
The purpose of this research is to support the clinical value of the Cionic Neural Sleeve for individuals diagnosed with multiple sclerosis (MS).
Eligibility criteria
Qualifiers
Persons with relapsing-remitting or progressive forms of MS between the ages of 22 and 75
Ability to ambulate at least 15 minutes throughout the day for five days per week, with or without assistive device
Adequate cognitive and communicative function as assessed via Telephone Interview for Cognitive Status (TICS) to identify persons with dementia
Able to tolerate the Neural Sleeve device for up to 8 hours per day
Disqualifiers
Lower motor neuron disease or injury (e.g. peripheral neuropathy) that may impair response to stimulation
Absent sensation in the impacted or more impacted leg
Inadequate response to stimulation, defined by inability to achieve muscle contraction or unable to tolerate stimulation
Inability to ambulate with the sleeve in place of an ankle foot orthosis (AFO)/knee ankle foot orthosis (KAFO) if utilized
Trial design
Treatments tested in this trial
- Cionic Neural Sleeve NS-100
- Walking Program